---
aliases: /news/why-digital-therapeutics-are-flourishing-under-covid-19
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - Why digital therapeutics are flourishing under COVID-19
categories:
  - 'Healthcare IT News: Digital Health'
categorySlug:
  - 'healthcare it news: digital health'
categoryUrl:
  - topic/healthcare-it-news-digital-health
categoryLabel:
  - Digital Health
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2020-09-18'
description: >-
  Efficient distribution, dissipating stigma and an emphasis on decentralized
  trials are all working in favor of digital treatments, according to a panel of
  digital therapeutics executives and industry 
favIconImage: null
featuredImage:
  alt: Why digital therapeutics are flourishing under COVID-19
  format: JPEG
  href: 51ce4ba6-60a7-52b6-ac73-2e0276a6fb2b-featuredImage.jpeg
  size:
    - 400
    - 712
  valid: true
  workPackage: 3417
  wpAttachment:
    fileName: Curated_Featured_Image.jpg
    link: /api/v3/attachments/9339/content
featuredPdf: null
htmlMetaData:
  author: null
  description: null
  generator: null
  viewport: null
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: null
  ogimage: null
  ogsite_name: null
  ogtitle: null
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 3417
identifier: News
lastMod: '2020-09-18T10:35:27.772049Z'
link:
  brand: mobihealthnews.com
  href: >-
    https://www.mobihealthnews.com/news/why-digital-therapeutics-are-flourishing-under-covid-19
  original: >-
    https://www.mobihealthnews.com/news/why-digital-therapeutics-are-flourishing-under-covid-19
href: >-
  https://www.mobihealthnews.com/news/why-digital-therapeutics-are-flourishing-under-covid-19
original: >-
  https://www.mobihealthnews.com/news/why-digital-therapeutics-are-flourishing-under-covid-19
mastHead: NEWS
mdName: 51ce4ba6-60a7-52b6-ac73-2e0276a6fb2b.md
openGraphMetaData:
  ogdescription: null
  ogtitle: null
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.mobihealthnews.com/news/why-digital-therapeutics-are-flourishing-under-covid-19
  medigyTopics:
    - 'Healthcare IT News: Digital Health'
  sourceUrl: >-
    https://www.mobihealthnews.com/news/why-digital-therapeutics-are-flourishing-under-covid-19
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: mobihealthnews-why-digital-therapeutics-are-flourishing-under-covid-19
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: Why digital therapeutics are flourishing under COVID-19
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: m.Doc Smart Clinic
    permalink: /offering/m-doc-smart-clinic
    categories:
      - 'Healthcare IT News: Remote Patient Monitoring'
      - 'Healthcare IT News: Digital Health'
    offeringId: 17554
  - label: Luscii Platform
    permalink: /offering/luscii-platform
    categories:
      - 'Healthcare IT News: Remote Patient Monitoring'
      - 'Healthcare IT News: Digital Health'
    offeringId: 17551
  - label: BPAUS Platform
    permalink: /offering/bpaus-platform
    categories:
      - 'Healthcare IT News: Remote Patient Monitoring'
      - 'Healthcare IT News: Digital Health'
    offeringId: 17521
  - label: Kaia Health Platform
    permalink: /offering/kaia-health-platform
    categories:
      - 'Healthcare IT News: Remote Patient Monitoring'
      - 'Healthcare IT News: Digital Health'
    offeringId: 17497
  - label: DynamiCare's Digital Recovery Platform
    permalink: /offering/dynamicares-digital-recovery-platform
    categories:
      - 'Healthcare IT News: Digital Health'
    offeringId: 17465
twitterMetaData:
  twittercard: null
  twitterdescription: null
  twittertitle: null
  twitterimage: null
  twitterurl: null
---
<p>Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.<br><br>The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape.</p><p>One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking in a virtual panel at the <a href="https://www.dtxeast.com/">DTx East 2020 web conference</a>, digital therapeutics executives and other industry stakeholders reaffirmed the increased demand for efficient and scalable treatments as providers find their services stretched thin, and patients find themselves cut off from in-person care.</p>